Due to the sturdy photoluminescence and absorption, CQDs emerged as a suitable candidate for optical sensing probe. The present study deals with the synthesis of blue-fluorescent Carbon Quantum Dot (TAA-CQD) using tannic acid and glycine as novel precursors. The TAA-CQD were synthesised hydrothermally with the high production yield and QY to be 86.12 and 21%, respectively, and an average particle size of 1.9 nm. The TAA-CQD aqueous solution displays excitation-dependent fluorescence emission in the excited range from 420 to 650 nm. The CIE co-ordinates in a highly blue region at (0.14, 0.19) confirmed the synthesised TAA-CQD were blue in fluorescent. Fluorescence of TAA-CQD was stable under all pH range, resisted the high ionic strengths condition and stable over 8 months. Furthermore, the fluorescent TAA-CQD was capable in detecting a tetracycline-classed antibiotic Doxycycline (DXY) along with remarkable selectivity and sensitivity. The measures limit of detection (LOD) was very low 2.42 mM in comparison to other methods. Moreover, the applicability of the proposed work has been fruitfully employed on the pharmaceutical waste. Thus, our designed TAA-CQD based fluorescence sensing system hold great promise for the advanced sensing materials in the detection of DXY and we believe that our approach will be promising and viable in a clinical applications.

An 8-year-old castrated male Maltese dog (patient) was referred to our institute with refractory canine babesiosis. The patient had previously responded to conventional treatment with atovaquone and azithromycin; however, anemia had recurred at six weeks after treatment withdrawal. No effect was observed on the administration of the same medication along with diminazene aceturate. On blood analysis, mild anemia was identified, with the absolute reticulocyte count indicating a markedly regenerative state. On Diff-Quik-stained peripheral blood film examination, the parasitic protozoan Babesia gibsoni was observed, and based on further laboratory examinations, a relapse of babesiosis was confirmed. Based on a previous study of drug-resistant variants of B. gibsoni and therapeutic trials, the treatment was then changed to a combination therapy of clindamycin, doxycycline, and metronidazole. Subsequently, the patient’s condition improved rapidly — B. gibsoni was not detected in the blood film and the PCR analysis for it was negative. This treatment was discontinued at six weeks after treatment initiation; however, at seven weeks after the treatment withdrawal, another relapse of babesiosis was confirmed and treatment was restarted with the same protocol. This treatment was effective again and lasted for 12 weeks. However, anemia recurred again at five weeks after withdrawal of the previous treatment and was corrected by restarting the same treatment protocol. This third treatment continued for 24 weeks and was finally stopped at the request of the client. The patient has reportedly been doing well with no manifestation of clinical signs and symptoms. This case report demonstrates that the clindamycin- doxycycline-metronidazole combination therapy against atovaquone and azithromycin-resistant B. gibsoni may be effective in improving the clinical manifestation of symptoms of canine babesiosis and this therapy may be an alternative treatment strategy.

A voltammetric analysis of doxycycline was developed using DNA immobilized onto a carbon nanotube paste electrode (PE). An anodic peak current was indicated at 0.2 V (versus Ag/AgCl) in a 0.1M NH4H2PO4 electrolyte solution. The linear working range of the cyclic and square wave stripping voltammetry was obtained to 1-27 ngL-1 with an accumulation time of 800 s. Final analytical parameters were optimized to be as follows: amplitude, 0.35 V; frequency, 500 Hz; and pH, 5.43. Here detection limit was found to be 0.45 ngL-1, this result can be applied in foods systems and in the biological diagnostics